Artemis Investment Management LLP 13D and 13G filings for BioXcel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-17 08:51 am Sale |
2022-12-30 | 13G | BioXcel Therapeutics, Inc. BTAI |
Artemis Investment Management LLP | 0 0.000% |
-88,149 (Position Closed) |
Filing |
| 2022-02-02 11:44 am Purchase |
2021-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
Artemis Investment Management LLP | 88,149 5.000% |
21,049 (+31.37%) |
Filing |